<SEC-DOCUMENT>0001437749-20-014399.txt : 20200702
<SEC-HEADER>0001437749-20-014399.hdr.sgml : 20200702
<ACCEPTANCE-DATETIME>20200701173917
ACCESSION NUMBER:		0001437749-20-014399
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200701
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200702
DATE AS OF CHANGE:		20200701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOLIFE SOLUTIONS INC
		CENTRAL INDEX KEY:			0000834365
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				943076866
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36362
		FILM NUMBER:		201006241

	BUSINESS ADDRESS:	
		STREET 1:		3303 MONTE VILLA PARKWAY
		STREET 2:		SUITE 310
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4254011400

	MAIL ADDRESS:	
		STREET 1:		3303 MONTE VILLA PARKWAY
		STREET 2:		SUITE 310
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOLIFE SOLUTION INC
		DATE OF NAME CHANGE:	20030113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOMEDICAL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bioli20200701_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head>
	<title>bioli20200701_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 7/1/2020 7:38:08 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>UNITED STATES</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Washington, D.C. 20549</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FORM 8-K</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Securities Exchange Act of 1934</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of Report (Date of earliest event reported): <b>July 1</b><b>, 2020</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 12pt; margin: 0pt; text-align: center;"><b>BIOLIFE SOLUTIONS, INC.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact name of registrant as specified in its charter)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="margin-left: 10%; width: 80%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Delaware</b></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>001-36362</b></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>94-3076866</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State or other jurisdiction of<br>
			incorporation)</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(IRS Employer Identification No.)</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>3303 Monte Villa Parkway, </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Bothell, WA 98021</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of principal executive offices) (Zip Code)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Registrant&#8217;s telephone number, including area code: <b>(425) 402-1400</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>N/A</b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Former name or former address, if changed since last report)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td>
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">Emerging growth company&nbsp;&#9744;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table cellpadding="2pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;">Title of each class</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 20%; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;">Trading symbol</p>
			</td>
			<td style="vertical-align: top; border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;">Name of exchange on which registered</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 40%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>BioLife Solutions, Inc. Common Shares</b></p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;"><b>BLFS</b></p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 40%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;"><b>NASDAQ Capital Market</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><b>&nbsp;</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Item 2.02</b></p>
			</td>
			<td>
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Results of Operations and Financial Condition.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">On July 1, 2020, BioLife Solutions, Inc. issued a press release announcing preliminary revenue results for the second quarter ended June 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Item 9.01 </b></p>
			</td>
			<td>
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Financial Statements and Exhibits.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(d)&nbsp;Exhibits</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 10%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Exhibit&nbsp;No.</b></p>
			</td>
			<td style="vertical-align: bottom; width: 5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 85%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Description</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 10%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">99.1</p>
			</td>
			<td style="vertical-align: bottom; width: 5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 85%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><a href="ex_192555.htm" style="-sec-extract:exhibit;">Press release, dated July 1, 2020</a></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><b>&nbsp;</b></p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURE</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align: top; width: 3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Biolife Solutions, Inc.</b></p>
			</td>
			<td style="vertical-align: top; width: 10%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Date: July 1, 2020</p>
			</td>
			<td style="vertical-align: top; width: 3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 40%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Roderick de Greef</p>
			</td>
			<td style="vertical-align: top; width: 10%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align: bottom; width: 40%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Name: Roderick de Greef</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Title: Chief Financial Officer and Chief Operating Officer</p>
			</td>
			<td style="vertical-align: top; width: 10%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_192555.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_192555.htm</title>

	<!-- Generated by ThunderDome Portal - 7/1/2020 7:23:30 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; margin-top: 0px; text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="" src="biolife.jpg"></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family: Times New Roman; font-size: 14pt; margin: 0pt; text-align: center;"><b>Bi</b><b>oLife Solutions </b><b>Announces </b><b>$9.6 </b><b>M</b><b>illion to </b><b>$9.8 Million in </b><b>Preliminary Revenue for Q2 2020</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:justify;"><i>&nbsp;</i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>BOTHELL, </b><b>Wash. (</b><b>July </b><b>1</b><b>, 2020</b><b>)</b><b> </b><b>&#8211; </b><b>BioLife Solutions</b><b>, Inc. (NASDAQ: BLFS)</b> (&#8220;BioLife&#8221; or the &#8220;Company&#8221;), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced estimated preliminary revenue for the second quarter of 2020 of $9.6 million to $9.8 million, representing 43% to 46% growth over the same quarter in 2019.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Mike Rice, BioLife&#8217;s CEO, commented, &#8220;Despite the continued impact of COVID-19 on the biotech industry and specifically, the cell and gene therapy market, we continued to drive revenue growth in the second quarter. In the first six months of 2020, we added 57 new customers and confirmed that our biopreservation media products have been embedded in 23 additional customer clinical trials.&#8221;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The financial data presented for the second quarter of 2020 should be considered preliminary and could be subject to change as these preliminary results are based on management's initial analysis of operations and are subject to further internal review and the Company's independent auditor, BDO USA, LLP, who have not completed their review.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>About BioLife Solutions</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">BioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools. Our tools portfolio includes our proprietary CryoStor<sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup><sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup>freeze media and HypoThermosol<sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup> shipping and storage media, ThawSTAR<sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup> family of automated, water-free thawing products, evo<sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup> cold chain management system, and Custom Biogenic Systems high capacity storage freezers. For more information, please visit www.biolifesolutions.com, and follow BioLife on Twitter.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Cautions Regarding Forward Looking Statements</b><b> </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company following the completion of its 2019 acquisitions and giving effect to the COVID-19 pandemic, the company's ability to implement its business strategy and anticipated business and operations, in particular following its 2019 acquisitions and giving effect to the COVID-19 pandemic, the company's anticipated future growth strategy, including the acquisition of synergistic cell and gene therapy manufacturing tools and services or technologies, the potential utility of and market for our products and services, potential revenue growth and market expansion, regulatory approvals and/or commercial manufacturing of our customers' products, and potential customer revenue. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including among other things, uncertainty regarding unexpected costs, charges or expenses resulting from the company&#8217;s 2019 acquisitions, market adoption of the company&#8217;s products (including the company&#8217;s recently acquired products); the ability of the company&#8217;s 2019 acquisitions to be accretive on the company&#8217;s financial results; the ability of the company to implement its business strategy; uncertainty regarding third-party market projections; market volatility; competition; litigation; the impact of the COVID-19 pandemic; and those other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law</i><i>.</i><i> </i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="margin-left:0%;width:33.9%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:bottom;width:94.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Media &amp; Investor Relations</b></p>
			</td>
			<td style="vertical-align:bottom;width:2.8%;">&nbsp;</td>
			<td style="vertical-align:middle;width:3.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:94.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Roderick de Greef</p>
			</td>
			<td style="vertical-align:bottom;width:2.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align:middle;width:3.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:94.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Chief Financial Officer</p>
			</td>
			<td style="vertical-align:bottom;width:2.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align:middle;width:3.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:94.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(425) 686-6002</p>
			</td>
			<td style="vertical-align:bottom;width:2.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align:middle;width:3.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:94.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">rdegreef@biolifesolutions.com</p>
			</td>
			<td style="vertical-align:bottom;width:2.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
			<td style="vertical-align:middle;width:3.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-transform:uppercase;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-transform:uppercase;"><b>&nbsp;</b></p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>biolife.jpg
<TEXT>
begin 644 biolife.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !5 A@# 2(  A$! Q$!_\0
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MZKUJG+=M;7V,*F*J*JZ5.%[:[V/VZL_BMX8U"ZC@@\1:'--,P2...^B9G8\
M !LDUJ:UK]CX;L3=:A>6MC; A3+<2K&@)Z#)(%?E+^SM_P &H7@C]GCX^>"_
M'MI\7_%^I77@S6[36H;2;3(5CN7MY5E",1(2 2N"?>O2?^#J,D?\$C-?P2/^
M*DTCD''_ "\5E]5HSKPI49W4G:]K6+]O4C3E4J1M;S/OC_A<7A+_ *&?P_\
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M#? 'BSQ-I[>';"#[7I^FRS0!U:;<I<#:",C//&17J_\ P3[_ ."=7Q/\0_\
M!/+XM?!OXJZ-_P (AI?B2>+4_#=Q?31RO8W. SN8U8LBJ\,3'.,[G]37&?\
M!;;_ (*(_&;]G']LF7P?X(\<WGAWP]_8-G=_9K>UMR1+(90[;V0OSM7OCBO/
M?^"*O[8/Q ^+?_!1K2[+QOXT\1>*+?Q!HFH61@U"]>6 ,(Q,"(L[ ?W9&0O0
MU]O[#.ZG"=*M%TXTZ4(U(M<SG[GO)ZVBGIKN9>VRB'$]2E)5)5*LI0DGRJ'O
M^Z^[:U\C>\.?'/\ 9L_X)!^?/\.;F7XV_&<0O:MK/F^7IFF[AMD577*@'H0N
M]CCDK7ZP_LO_ +0&D?M2_ +POX]T1O\ 0?$=BEP8B<M;2_=EA;_:20,I_P!V
MOYF/C=X33P!\:?&&A1J$CT77+VQ1?18KAT'Z**_6_P#X-G?C-/XB^!GC_P "
MW$QD7PQJL.I6BD_ZN*[1@RCV\R!C]6/K7-XB\(THY.LWC4E4JIQ<I2>KC+2U
MEHDFU9):79OP)Q34EFKRMPC3I--1C%;2CK>^[;2=VWV-W_@Z@_Y1"^)?^QBT
M?_TJ6OR(_P""//\ P7?;_@DY\'/%?A,?#C_A-/\ A)]975OM/]K"S^SX@2+9
MM\ML_=SG(ZU^N_\ P=0?\HA?$O\ V,6C_P#I4M?,?_!II^SW\._C%^R9\3KS
MQEX'\%^*;RU\7)#!/K6C6U]+#']CB.Q6E1B%R2<#C)-?E6!G2CE<G6CS1YMM
MNQ^H8F,Y8V*INSL?GW^UY^V]XG_X+V?MS>"+7Q-J/@KX2:,B#1=);4]1*V.D
MQ22!Y9)9V \R9SC  &=J*/4_U!?LU_!+1_V;/V??!G@'P^[3:-X0T:VTJTF;
M&Z=(HU7S#CC+8+''&6K\(_\ @["_9;^"7P'\2?"_5/A_HOAOPMXU\0->IK.E
MZ-%';Q3V:+'Y4[P1X5"'+*& &[)Z[:_3K_@W>^*OB7XO_P#!(SX5ZEXIGNKR
M_LH[W2K>ZN&+27-K;7DT$!)/)Q&BIGOLK/-;5,%2K4O=AMR_?KY[%8&\,3.G
M4UEO<_"O_@D;_P I_O G_8_:Q_Z+OJ_4?_@[[^)^H>%/V!_ _ANUD>.S\6^,
M8EO0IQYJ6]M-,J'U&_:V/5!Z5^7'_!(W_E/]X$_['[6/_1=]7[._\'-W[(>J
M?M2_\$T=1U+0+.6_UOX::G%XG2WB7=)-:HCQ704=RL4AD^D1KLQTHQS&@Y[6
M7YLPPRE+!U5'>[/)?^#0[X!:)X4_8:\7?$1+:%_$?C#Q//ITUT5!DCM+2.(1
MP@]0/,DE8COE?2OUJK^?;_@UL_X*P>#OV;(_$'P-^(VLVGA[2_$VJ#6?#>JW
MD@CM%NWC2*:UD<\)O$<;(20"0XZD9_?>3QAI,.DF_;5-/6Q">8;@W">4%ZYW
M9QBO%SJE4CBYN?7;T/1RVI"6'BH]#\B_^#P?X#:+KG[*?PZ^)/V>&/Q'X>\1
MC1/M(4"2>SN899#$3U(62%6'IN?UKO/^#2'XH:AXU_X)JZWH=Y))+;^#O&5Y
M8V6\D^7%+#;W)0>P>9S]6-?$W_!T5_P5:\'_ +6?B+PQ\'/AQJ]MXA\/^"=0
MDU77=7M)!):75_L:*.")QPXB5Y2S#(W. .5-?I?_ ,&W_P"R'JO[)/\ P3$\
M-+K]K+8Z_P"/KR;Q7=6TJ%9+:.<(MNC ]&\B.)B.V_':N^O&5/*8PJ[MZ+^O
MZU.6DU/'RE3V2U/A3P)_RN.WO_7U=_\ J./7[OU^$'@3_E<=O?\ KZN__4<>
MOW?K@S;>E_@B=.7[5/\ $_T"OQ#7_E<:_P"X<?\ TPU^WE?B&O\ RN-?]PX_
M^F&EE7_+[_!+]"L=_P N_P#$CU3_ (/!.?V ? ?_ &/$/_I'<UPG[&?_  =*
M_ #]GC]DCX9^ ]9\.?$N?5_!OAC3M%O9+73;=X))K>W2)RA,X)4LIP2!QVKN
M_P#@\$_Y, \!_P#8\0_^D=S7TI_P3>_8&^"'C3_@GW\$]7U?X1_#G4M4U+P/
MI%U=W=SX?M99KF5[.)GD=V0EF8DDDG))KKA*A'+X>WBVN9[.QS255XN7LFEH
MMSG/V#_^#B#X+_\ !0G]I/2OA=X,T+Q]8Z_K%M<W4,VJ6$$5LJP1-*^YEF8Y
M*J<<=:YK_@ZD_P"41>O_ /8R:1_Z45]H?#;]C#X1_!OQ=!K_ (3^&?@;PUK=
MLCQPW^F:+;VMQ&KJ5<!T4, 02#SR*^+_ /@ZD_Y1%Z__ -C)I'_I17)AI47C
M:;HII76^O4Z*RJ+#3]J[NS/B7_@FU_P<X_#;]B3]A[X>?"O6OASX]UC5/!M@
M]I<7MB;7[/<,T\LN4W2!L8<#D=J^OOV,_P#@Y[^&O[:'[4'@WX7:-\./'ND:
MGXSO396]Y?-:_9[=A&\F7VR%L80C@=Z]!_X(4_LW_#OQI_P26^">J:QX!\%Z
MKJ5WHTK3W=YH=M//.1=SC+.R%F. !R>U?8/AS]FOX=>#];M]3TGP!X*TO4K-
MM]O=V>AVL$\#8(RKJ@93@GH>]:XRM@_:37LWS7>M^O<C#4\1R1?/I9=#MJ**
M*\4](**** //_P!K#_DUSXC_ /8L:E_Z2R5UO@K_ )$W2?\ KRA_] %<E^UA
M_P FN?$?_L6-2_\ 262NM\%?\B;I/_7E#_Z *O["]?\ (C[9IT445!84444
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M,/[1^P?\(YMOX+K[+L^T?:/]7&FW=NAZYSMKSM?^"5GQ1'_!PE_PTQ_Q(/\
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M;[0M+O/"OB/PM=+%J&A7\Z2W"0.,Q7*E>&C8AER.C*0>HSU?[2__  41T_\
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M?T/VB4;5P. .@%+5;1M/_LC2+6T\V2?[-"D/F2'+2;5 W'W.*LUX1Z84444
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MCBUZWOK;6+G3/%-UK%YK&FG4YELM4?5(HXKKSHE(#C;$NS/^K))7!-<_I_\
MP3/^':Z!KMKJU[XS\3:EKD-C;C6]7UV6XU738[&8SV:VLXVF'R9F,BD#)<DL
M6S7?&KAU=R6YR2A6TLSYZUS_ (*)>.- \->'/ 6D:IXF\0?$_P 2>*K[2=1^
MV> S!JWAR"UL(KV1%TY)RDKO'+$T4C3"/9*6+'R\-[=IW[>.C_#G]@VP^(U]
MK5SXQU6:Y?0;2.[TX:)>:EK1NI+:.PFMV8BWE69?+D);:HC=_NBMS_AVW\/U
M\)I:K?>,8_$4>M/X@_X2U=9?_A(&O7@%LTAN<8*FW A\O9Y>P ;<C-;G@C]@
MOX:>"-,L-/&C2ZSI-AI[V/\ 9NM7#:E974DER]U)>30S;DDNWFD<M.1OPQ&0
M.*4ZE!I677RU'&%9-W9\P_#?]M'XH>/OV6QKGB'XJ_"_PF_AKQ9KND>+O%-E
M8?;$C%M.T5A;6-H9<RM.W1BQ9EC^5<N-N5X]_P""I_Q&TGPQ\+-,G7PGX1\6
MV-SX<G^)ZZM&8C:IJ=Y%!'96\#N'CN'@D:ZDW%OLZ!5;+.*]]UO_ ())_!Z[
MBTD:-8:SX.ET3Q!?^)[2;PY>C3I([Z\R)),HN#L5F2(8_=*[!<9KJO%O_!.O
MX3_$;P1I>C^*?#%GXKN-+N;2[.LZQ!#=ZO>O;3+-&)[ID\R5<HJLK'#)\IXJ
M_;8>][:7[?U_5OG/LZUK7.,_X*!?M>>)_A!XT^&O@/P';:A-K_Q(74;[[=IV
MBMK5S:V5C'"TOD6P>-&D=KF(!I'5%7<3N.U3X]\0/V\O'+^&/!^O:)XJ\3K\
M-K/PC)K'B/QM;?#:2_"W:WLT$T=U;B=?L?V9+:4S+EF!.0, U]->/?V#O!OC
MS$YU+QCI.K6VKW&L:=JNG:U+#>:.UQ#'#-;VS'<L5J\<: P!=@(! ! (YK6?
M^"6/PJU+0;#2;5?%>C:1#I2Z)J=CIVO7$,'B.S$LDQBOADF8M)-,S/E7;SG!
M8@XJ*=2A&*36OHOZ[6*G"JVVCR_XE?\ !2^^U+]MCP'X5\'^(/"$7PYM_$X\
M)^);Z[=6NM7OY=/GNMEK\X\N*W\N%7D((>2XV+RC&MGX ?'3XJ6W_!1+5?AS
MXV\907'A*#19+K0S>^$&TM_%]P/+>5["X6:2.2"U21 ^3O9GX4*I:O:/'7[!
M?P@^(GBWP]KFH_#WPF=4\-:F-6M;B+2K='FF$4D0\X[,RJ%D)VL3\RJ>JBL_
MX)_L!> _@-\0K'Q%I$OB:]DT*WN;/P_8ZIJ\MY9>&H+A@9H[.-_]6&"JOS%B
M%4*"%XI>UH\MDNEMNO>X<E7FNWU/F+XD_M%?%_5/VO/BQHO@?Q!\0=4UWPEX
MXT72M!\-V_AE+CPQ)82V&F3W0O;[R1Y'$]RY8SAE^3"MP#O_ +//_!4>]^'7
MPK6\^+7A_P 1QZ0P\67UCXK+VTL>JQZ3>W!>%8(V\U"+=56,LH#F,\\@G["\
M ?!S0_AIXM\8ZWI44\=_X[U2/5]69Y2ZR7"6D%HI4?PCRK:(8'<$]ZX&7]@+
MX97OA+0]!O=&GU#1M &LK!:7-RSQRIJWF_;4DZ%@WFOCD%<C!XI^WHM<LH]O
M7;_,/95$^9/O^?\ D>>>)/\ @IK<?#:"\L/%_P *?%^@^+_^)--IN@"]L;F;
M5;?5-133H725)C$KQW$BK(CL"N01N!!K%\9_\%?=$^'WARVM=;\&ZAI'CN3Q
M'J7AJ?P_?ZO8VT=M-86]O<SRF\>40&,PW=J4PVYFG"X&&QZ3X;_X)Q?#[1(W
M>^NO%OB74#>:3=1ZCK>LR7EY;QZ7=I>65LDA VPI.@<KC+DG>S'FK_C/]@3P
M+XNU/4-3@G\2^'_$%_X@N?$HUG2-3:VO[6ZN;6"TN%C?! BDAMH5:,J5)0-U
M (2EAKZK^OOV_$.6O;1G<_L[?'/2?VE_@?X9\>:%'=P:5XHL4O8(;I-DT&<A
MD< D;E8,IP2.."17$?L >)M2\6_L\S7FJW]YJ5V/%?B2W$US*99!'%K=]'&F
M3SM1$55'8*!VKU+X>> ]/^%_@;2O#VE?:O[.T>V2U@-U<R7,S*HQEY9"7=CU
M+,222:YG]FKX*/\  #X8OX>>_74B^LZKJOG+%Y>!>ZA<7@3&3]SS]N>^W/>N
M=N/+)+OIZ:FR4N9-]O\ (\W^!7[17CC6OVLOCAX8\?0^&=%\,^!-/TG4M%^P
MSO,R6EPMX9)KF5E4!C]G!VA<(!]YNM>!_#/_ (*0_$?]HWXT>.K/P7JGP\L-
M$UKP4GB'X?VVJR8FMHEOVMGO[Y@XX>W1[I8,*5C\L,P+''UMXL_9*\)>,?B+
MJGBFX_MF#5=;FTJ6_-KJ$D$=XNG-,T$,B*0'A/GR"2-LK(#A@17"?%+_ ()7
M? _XJSZ]++X)TS0I_$>@#PW=RZ#!%ICBS\_SF"&)!M=SE'8<M&2ARIQ71"I0
MNW)=OTN92A5MH^YX):_MC?&S5OAIJ$?A2]OOB%I+>.+?1](\>:'X+:X?4M+7
M3Y+B]FCL1,$E6.Z1;99UD$;>83_ <^U6W[>&C?#K]@[3_B9>:Z_C34+RX;1;
M%9=._L2XU363=26J6$EN[-]FD2=&CDW,0@BD8G K53_@G#X37PM9Z>?%_P 4
M'NM(O%O=(U1O$LGV[16$+0-';OMVK$\;%6C*LAP. 0".A\%_L&_#3P5I>G:<
MNBR:OHVFZ<]@NEZS<-J5A<2273W4MY+!-N22\>:61FG8;SYC#.#BG.I0?3KV
M_K^N@HPJH^8O@#^V[\6/CYX6\$> O^$Q\#V_Q#\2>-_%.B:OXDTK3OM=E866
MD/(0+>W,OS22@PA&=L% [X/ J/QU^VE\88O@_J5_/XU\%^%;[P+J6N>%I+B'
M0WU"\\>>(;*[,5G:6=CYH=8YH@&<(SN'<J" NX_0J_\ !,_X3Z1X.DTGP]HU
MQX.F_P"$DN?%=MJ?AZ8:?J%A?W!E\QHI47B/9-)&(F#((VVXP!C)UG_@E5\-
M;V_\)WNG:EX]\.ZEX-L;RQL+[2O$,L%T_P!LG\^[GDD(9GGGE^9Y/O-T^[Q5
M^VP_->VGHO/_ (")]G6MO^/H0_M/?M&?%CX5_#OX*:M8Z%X:TEO%?B3P_I?C
M-;ZY>2;2A>S0Q36]M&%VNP>1E\QG&T+G:V>/-/@W_P %%M?_ &F/VSI_#^@^
M*/!^B?#3Q9X1UJ;P?.R+<:E-=V-U9VZZE(ID4>3*;B=HH"%9H[<.6 ?CZ-U#
M]C7PIKEN8]4O?%&L ZKI&M#[?K$MP([K3!&+=U#'"Y,:M(% $C$D\FLOQ'_P
M3E^"?B?QO_;\WPX\*V][_8=]X>=;/3H;2-[6\\OSR1$JD2D1A5D!#*KN 1N-
M90J45&TEJ7*%5NZ9\[_!/]H'XW>.-6^-N@:WXZETOQ!X%:*Y\/Z/-\/C%KVK
M6,1G5[R*V:Y$<T=W)&4@\N0D>7EL%PHZKX _M1_$/QA_P2U^)7COQ)XCL)OB
M;X:TO7I9X8-&?39O"]Y;VSR165S;REO](A'ELY^XQ?Y<KAF[VU_X)>?#D:/>
M)>ZEX[U?69OL2V6OWWB":75]&2R=GM4M9^/+5&=S@@[]QW[Z[KP9^QUX-\%?
M KQ3\/XEU:_TOQPMZ?$%[?7S3ZCJ\MW%Y4\TLQY\PQ[5!  4(H  %7.M1>RZ
MKHOF3"G46[Z/J?,?P)_;-U'X5?!*/QCJNL_%_P ?7FIQ:99M:^--)M/"^GVL
M]Q$\K3Q7,T-NC1_NV!.Y_O1@ EA7=Z=_P5N\,ZQX<^&U]:>#/%EU)\8+,?\
M"'P1>0W]KZ@ET8+K3]_F;(Y(%#3-(Y$;1([*S;2*]D^+G[(OA;XQ>#?!VD7L
MVMZ8W@"ZAO-!U#3+TP7NGRQV[VVY7((.Z&1T.0>&)&#@CAK'_@EO\)K#PQI.
MEBQUR1/#EDMEH5Q+JLKW.@$7S7YGM9#\T<[7!!>7EG5%1B5R"O:8>6LEK_7_
M  /Q'RUEHF?1*DE1D8..1Z44(NQ ,EL#&3U-%<)U"T444 %1"SB6X\X11^;C
M&_:-V/KUJ6B@!@A192X10[#!;')'UI]%% !1110 45\H_P#!9'XW?$'X"?LA
M6^L?#^^U'0?M7B73-/\ $OB+3],_M*[\+:)+*1>:A%;X(=XQM'((&\G'%?"'
MQ[_;S^+?A+]ECX>W/@GXS^,_%OPVU3QIJ^G:O\3[_P -KH%]#;PVT3V-OYKV
M\L1B>9I1]I$ #F,(-IYKMH8&=6*E%K5VZG-5Q4:;::V/UM\;_M ^!_AKX@NM
M*\0>*]!T;4K+1I_$5Q:WEXD4L.FPG;->,I.1"AX9^@]:Z+PUXDL/&7ARPU?2
MKRWU'2]5MH[RSN[=Q)%=0R*'21&'#*RD$$=017XE_$/Q1\1OC=IZ>*/B%&^K
M>+=8_8\\8QW=_;Z?+ NH,;YQ YC9%*R21"-BNT9)) P17UO^TK\>O$7[,G_!
M$CX(:CH6K^(O"FHWVB>$-%N-3TNU@,VF0RVD E>62X!CM8P%*M.Z/LR/D)-:
M3P'+RQ3U;L9QQ=[MK1*Y^A=17M[%IUG+<3R)#! ADDD<X5% R23Z 5^-GP(_
M:M_:-_:?\$?L]^#F^*GBKPE=^*_&WC;PYK/B6RTJVN+RYL+"U2:QD<R0K&7R
M2HD"(&!SM[5R^N_\%!?C9X]_9[^"1^)GQ4\7_"KPYXB\ :U//XDT?PHM]<>+
MO$-MJ$]I#87"&)A'OMT1]BJI<N<$9&*_LNI>W,OQ\_+R8OKT.S_JW^9^TWP[
M^(V@_%SP3IWB3PQJ^GZ_H&KQ>?8ZA8SK/;7<>2-R.N0PR#R/2MJOR_\ @CX_
M^*'P%_X-F_ &L?#&UN[3QMIGAJU3='9B>\TVV:^*W,\-N_\ K)HX6=E0CDCH
M<8KY]A_X*)?'O1_AG^T=%X"^(OQ$\?:-X,OO!UM9:]XD\-Q:;K&@Z7??:#J-
M[]G$ P5*JHD>)@$^?80.4LME)RY&K)V_%+]?S&\;&*CS+=7_  O^A^X5%?C=
M\)_VH_VC/CA\,/@IH%I\7-;LK#QW\6M3\,0^,-.T^&\O;K1$TTRJ9'DMHX96
M28,%G2-5;C@E2#PWQ0_X*.?M+Z7^RG\&3J_C76O#>G3R^*M.UGQK':16=QJ>
MHZ??/!I\,[-;31Q[X@'V+&IG(PK+BFLKJ-\O,K_\/Y>0?7H6O9_U;_,_<:ZN
MXK&!I9I(X8DY9W8*J_4FL31?BGX;\2>/-:\+V&N:9>>(_#D<$NJ:;#<*UUIZ
M3 M"TJ Y0. 2N>N*_/#_ (*BVWQ2^.W_  ;V+XAUO5]6TSQW%H&D:UXA@T*R
M:/\ MA?.A\Y7C=1+$FU_/8 *RF+'W<BOF#XL>+/B5\-_CA\>OC3\*?BWXLNO
M^$6\,_#N]BOO[#@=/B'%.J0L]TK1Y0>6[L5B"D%N<8J:. ]I%OFUNU\[I?C<
M*N,Y))6TW_/_ "/W-HK\@_#/[=7[1^N_\%<QX0O_ !!<:+ /B"-(C\%7%MFR
MN_#'D[A>(BVS2;F7,GVDSB,-\A05FZ7^U9\>O"__  3WU[XI^+OC#XW\WQ=\
M2V\&Z?%9Z)8VO_"*V$.IW2-<2W4J;84DC15:XDC<(!& K%B:'ELU:\EK;\1_
M78N]D]+_ ('['45^'DO_  4N^+]U^SC^SD?'/QG\3?#>Q\1>-?&'ASQ/XJLM
M$AN[^?3[%8S:3/&8,%AN \U8U&#O*\$5N:A_P4"_:I^#/[)?PT^+$>K:SXYL
M_'=[KGPRTFTO]-BL+C6+J::4>'M?\DH&5WV%9$'RLJJ=H+9J_P"RJJZK>WY_
M+H+Z]#L_ZM_F?M'=7<5C 9)I(X8UZN[!5';J:DK\X_\ @M=\&/B'H_\ P122
MQO/'OBG4_%7@Y=%NO$VHV%M&TNOE;F!;J20(@VQ(S-.-@'^I4'(S7SY^V+^W
MU\:/ 7Q7U*V\._%_QK:76C^&_#=W\(=)M?!ZWMO\96N88S<W%U((OE9V)#(A
MC\O).!BLZ. =6/-"2W:Z]+?Y_<54Q:A*TEV_&_\ D?L_6!\/_BGX<^*UIJ4_
MAK7-,UV'1]1GTB^>QN%F6TO(2!-;N5/RR(2 RGD9K\DOB)^WO^T/IO[<=_I<
MGB[Q-I'Q(M?B+INAZ+\'X/#(GT76?#4HA\_4&OO++?<>9S,) J&,#'->7_$'
M]H?XG?LG_ +QO?>"_%NJ^"K&]_: \?W.HV]E;)#J&MA&@:V2VFG@E@)W%B(&
MV-/D*C<$C2.63>EU=VM_7](B6.BM;:(_=RBN;^#OB.Y\8?"+PMJUY'?Q7FJ:
M/:7<\=];BWN4DDA1V$L0)"2 D[E!(4Y&3BNDKRWH['<M=0HHHH \_P#VL/\
MDUSXC_\ 8L:E_P"DLE=;X*_Y$W2?^O*'_P! %<E^U>"W[+OQ' !)/AC4L =_
M]%DKK?!?'@[2?^O*'_T 5?V%Z_Y$?;-.BBBH+"D9PBDG@ 9)]*6HK\9L9O\
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
